← Leaderboards
Lisa Charlotte Standke
Weill Medical Coll Of Cornell Univ
$133,584
Attributed
$133,584
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45K · FY2017–19$50K$37.5K$25K$12.5K$0
'17
'18
'19
Funding mix
By agency
NIH$133,584 · 1
By mechanism
F31$133,584 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Gary M Brittenham$18,110,961
- Sabine Ehrt$39,683,358
- Yi Wang$29,689,109
- Sujit S Sheth$1,707,497
- Alexander Shtilbans$1,551,122
Others in their field
Other Emerging Leaders on “Affinity”
- Bala Raja · Luminostics, Inc.$28,624,460
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$25,726,378
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Timothy M Willson · University Of Cape Town$13,865,323
Research focus
AffinityAnalogAnabolismAntibiotic ResistanceAntibioticsAntimicrobialAnti-Bacterial AgentsAntitubercular AntibioticsAreaBacteriaBindingBiochemicalBiological AvailabilityBiological SciencesCell GrowthCellular AssayCessation Of LifeChargeClinical DevelopmentClinical ResearchCollaborationsCollegeCommuneCost
Grant awards (3)
Development of Pharmacologically Optimized Inhibitors of M. tuberculosis MbtA as Novel Antibiotics$45,016
F31 · FY2019 · AI · contact PI
Development of Pharmacologically Optimized Inhibitors of M. tuberculosis MbtA as Novel Antibiotics$44,524
F31 · FY2018 · AI · contact PI
Development of Pharmacologically Optimized Inhibitors of M. tuberculosis MbtA as Novel Antibiotics$44,044
F31 · FY2017 · AI · contact PI